Research Paper Volume 14, Issue 9 pp 4158—4175

CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database

class="figure-viewer-img"

Figure 5. The survival analysis, differential analysis and GSEA of CCL19. (A) The survival analysis between the expression of CCL19 and the survival of breast cancer patients; patients were divided into two groups, high CCL19 expression group and low CCL19 expression group, compared with the median; (BF) The associations between the expression of CCL19 with age, stage, and TNM classification of breast cancer patients; p value was displayed in the diagram; (GJ) GSEA for genes in high CCL19 expression group in different gene sets, p<0.05 and FDR<0.05 were considered to be statistically significant.